A75 Trademark

Trademark Overview

On Friday, January 13, 2017, a trademark application was filed for A75 with the United States Patent and Trademark Office. The USPTO has given the A75 trademark a serial number of 87301607. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2020. This trademark is owned by AbbVie Inc.. The A75 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
a75

General Information

Serial Number87301607
Word MarkA75
Filing DateFriday, January 13, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a three-dimensional configuration of an oblong shaped tablet with the stylized letter "A" followed by the upright number "7" followed by a sideways number "5" imprinted on it. The broken or dotted lines depicting the shape of the tablet indicate placement of the mark on the goods and the tablet shape depicted in broken lines, is not part of the mark, and serves only to show the position or placement of the mark.
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 23, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, November 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, March 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2020EXTENSION 2 GRANTED
Wednesday, March 18, 2020EXTENSION 2 FILED
Wednesday, March 18, 2020TEAS EXTENSION RECEIVED
Thursday, October 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2019EXTENSION 1 GRANTED
Tuesday, October 15, 2019EXTENSION 1 FILED
Tuesday, October 15, 2019TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 4, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 9, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 9, 2018FINAL REFUSAL E-MAILED
Monday, July 9, 2018FINAL REFUSAL WRITTEN
Saturday, June 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 1, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION WRITTEN
Thursday, November 9, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 3, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, September 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 17, 2017NON-FINAL ACTION E-MAILED
Friday, March 17, 2017NON-FINAL ACTION WRITTEN
Friday, March 10, 2017ASSIGNED TO EXAMINER
Tuesday, January 24, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related